Akt stimulates aerobic glycolysis in cancer cells

被引:1158
作者
Elstrom, RL
Bauer, DE
Buzzai, M
Karnauskas, R
Harris, MH
Plas, DR
Zhuang, HM
Cinalli, RM
Alavi, A
Rudin, CM
Thompson, CB [1 ]
机构
[1] Univ Penn, Dept Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Radiol, Div Nucl Med, Philadelphia, PA 19104 USA
[3] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[4] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
D O I
10.1158/0008-5472.CAN-03-2904
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer cells frequently display high rates of aerobic glycolysis in comparison to their nontransformed counterparts, although the molecular basis of this phenomenon remains poorly understood. Constitutive activity of the serine/threonine kinase Akt is a common perturbation observed in malignant cells. Surprisingly, although Akt activity is sufficient to promote leukemogenesis in nontransformed hematopoietic precursors and maintenance of Akt activity was required for rapid disease progression, the expression of activated Akt did not increase the proliferation of the premalignant or malignant cells in culture. However, Akt stimulated glucose consumption in transformed cells without affecting the rate of oxidative phosphorylation. High rates of aerobic glycolysis were also identified in human glioblastoma cells possessing but not those lacking constitutive Akt activity. Akt-expressing cells were more susceptible than control cells to death after glucose withdrawal. These data suggest that activation of the Akt oncogene is sufficient to stimulate the switch to aerobic glycolysis characteristic of cancer cells and that Akt activity renders cancer cells dependent on aerobic glycolysis for continued growth and survival.
引用
收藏
页码:3892 / 3899
页数:8
相关论文
共 39 条
[1]   Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1α nor sufficient for HIF-1-dependent target gene transcription [J].
Arsham, AM ;
Plas, DR ;
Thompson, CB ;
Simon, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :15162-15170
[2]   MOLECULAR ALTERATIONS OF THE AKT2 ONCOGENE IN OVARIAN AND BREAST CARCINOMAS [J].
BELLACOSA, A ;
DEFEO, D ;
GODWIN, AK ;
BELL, DW ;
CHENG, JQ ;
ALTOMARE, DA ;
WAN, MH ;
DUBEAU, L ;
SCAMBIA, G ;
MASCIULLO, V ;
FERRANDINA, G ;
PANICI, PB ;
MANCUSO, S ;
NERI, G ;
TESTA, JR .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) :280-285
[3]  
Blancher C, 2001, CANCER RES, V61, P7349
[4]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[5]   AKT2, A PUTATIVE ONCOGENE ENCODING A MEMBER OF A SUBFAMILY OF PROTEIN-SERINE THREONINE KINASES, IS AMPLIFIED IN HUMAN OVARIAN CARCINOMAS [J].
CHENG, JQ ;
GODWIN, AK ;
BELLACOSA, A ;
TAGUCHI, T ;
FRANKE, TF ;
HAMILTON, TC ;
TSICHLIS, PN ;
TESTA, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9267-9271
[6]   Transforming activity and mitosis-related expression of the AKT2 oncogene: Evidence suggesting a link between cell cycle regulation and oncogenesis [J].
Cheng, JQ ;
Altomare, DA ;
Klein, MA ;
Lee, WC ;
Kruh, GD ;
Lissy, NA ;
Testa, JR .
ONCOGENE, 1997, 14 (23) :2793-2801
[7]   Amplification of AKT2 in human pancreatic cancer cells and inhibition of ATK2 expression and tumorigenicity by antisense RNA [J].
Cheng, JQ ;
Ruggeri, B ;
Klein, WM ;
Sonoda, G ;
Altomare, DA ;
Watson, DK ;
Testa, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3636-3641
[8]   Oncogenic alterations of metabolism [J].
Dang, CV ;
Semenza, GL .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) :68-72
[9]   CHARACTERIZATION OF AN ESTABLISHED HUMAN-MALIGNANT GLIOMA CELL-LINE - LN-18 [J].
DISERENS, AC ;
DETRIBOLET, N ;
MARTINACHARD, A ;
GAIDE, AC ;
SCHNEGG, JF ;
CARREL, S .
ACTA NEUROPATHOLOGICA, 1981, 53 (01) :21-28
[10]   Regulation of neuronal survival by the serine-threonine protein kinase Akt [J].
Dudek, H ;
Datta, SR ;
Franke, TF ;
Birnbaum, MJ ;
Yao, RJ ;
Cooper, GM ;
Segal, RA ;
Kaplan, DR ;
Greenberg, ME .
SCIENCE, 1997, 275 (5300) :661-665